CLP induces apoptosis in human leukemia K562 cells through Ca(2+) regulating extracellular-related protein kinase ERK

C L Wang1, T B Ng, X H Cao

  • 1Department of Microbiology, College of Life Science, Nankai University, Tianjin, China.

Cancer Letters
|December 23, 2008
PubMed

Insights

Bacillus natto T-2 cyclic lipopeptide (CLP) triggers apoptosis in K562 leukemia cells by increasing intracellular calcium and activating ERK signaling. This pathway ultimately leads to programmed cell death.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Oncology

Background:

  • Cyclic lipopeptides (CLPs) are known to induce apoptosis in cancer cells.
  • The precise molecular mechanisms of CLP-induced apoptosis in human leukemic K562 cells remain unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying CLP-induced apoptosis in K562 cells.
  • To investigate the role of intracellular calcium and specific signaling pathways in CLP's apoptotic effects.

Main Methods:

  • Purification of CLP from Bacillus natto T-2.
  • Measurement of intracellular calcium ([Ca2+]i) levels.
  • Assessment of apoptosis and Western blotting for ERK, p38, and JNK phosphorylation.
  • Inhibition studies using PD98059 (ERK inhibitor), SB203580 (p38 inhibitor), SP200125 (JNK inhibitor), and Bapta-AM (calcium chelator).

Main Results:

  • CLP treatment led to a sustained increase in intracellular calcium ([Ca2+]i).
  • CLP induced K562 cell apoptosis and ERK phosphorylation.
  • Apoptosis was reversed by an ERK inhibitor (PD98059) but not by p38 or JNK inhibitors.
  • Calcium chelation partially blocked CLP-induced apoptosis.
  • CLP-induced apoptosis involved the activation of Bax, cytochrome c, and caspase-3.

Conclusions:

  • CLP induces apoptosis in K562 cells via a mechanism involving increased intracellular calcium and subsequent ERK pathway activation.
  • The findings highlight the critical role of the calcium-ERK signaling axis in CLP-mediated apoptosis of human leukemia cells.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.